Table of Content

1 Cannabinoid Derived Pharmaceutical Market Overview
1.1 Cannabinoid Derived Pharmaceutical Product Overview
1.2 Cannabinoid Derived Pharmaceutical Market Segment by Type
1.2.1 Cannabinoid Receptor Type 1 (CB1)
1.2.2 Cannabinoid Receptor Type 2 (CB2)
1.2.3 Others
1.3 Global Cannabinoid Derived Pharmaceutical Market Size by Type
1.3.1 Global Cannabinoid Derived Pharmaceutical Market Size Overview by Type (2024-2034)
1.3.2 Global Cannabinoid Derived Pharmaceutical Historic Market Size Review by Type (2024-2024)
1.3.3 Global Cannabinoid Derived Pharmaceutical Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cannabinoid Derived Pharmaceutical Sales Breakdown by Type (2024-2024)
1.4.2 Europe Cannabinoid Derived Pharmaceutical Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Cannabinoid Derived Pharmaceutical Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Breakdown by Type (2024-2024)
2 Global Cannabinoid Derived Pharmaceutical Market Competition by Company
2.1 Global Top Players by Cannabinoid Derived Pharmaceutical Sales (2024-2024)
2.2 Global Top Players by Cannabinoid Derived Pharmaceutical Revenue (2024-2024)
2.3 Global Top Players by Cannabinoid Derived Pharmaceutical Price (2024-2024)
2.4 Global Top Manufacturers Cannabinoid Derived Pharmaceutical Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cannabinoid Derived Pharmaceutical Market Competitive Situation and Trends
2.5.1 Cannabinoid Derived Pharmaceutical Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cannabinoid Derived Pharmaceutical Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2022)
2.7 Date of Key Manufacturers Enter into Cannabinoid Derived Pharmaceutical Market
2.8 Key Manufacturers Cannabinoid Derived Pharmaceutical Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cannabinoid Derived Pharmaceutical Status and Outlook by Region
3.1 Global Cannabinoid Derived Pharmaceutical Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Cannabinoid Derived Pharmaceutical Historic Market Size by Region
3.2.1 Global Cannabinoid Derived Pharmaceutical Sales in Volume by Region (2024-2024)
3.2.2 Global Cannabinoid Derived Pharmaceutical Sales in Value by Region (2024-2024)
3.2.3 Global Cannabinoid Derived Pharmaceutical Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Cannabinoid Derived Pharmaceutical Forecasted Market Size by Region
3.3.1 Global Cannabinoid Derived Pharmaceutical Sales in Volume by Region (2024-2034)
3.3.2 Global Cannabinoid Derived Pharmaceutical Sales in Value by Region (2024-2034)
3.3.3 Global Cannabinoid Derived Pharmaceutical Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cannabinoid Derived Pharmaceutical by Application
4.1 Cannabinoid Derived Pharmaceutical Market Segment by Application
4.1.1 Epilepsy
4.1.2 Migraine
4.1.3 Multiple Sclerosis
4.1.4 Others
4.2 Global Cannabinoid Derived Pharmaceutical Market Size by Application
4.2.1 Global Cannabinoid Derived Pharmaceutical Market Size Overview by Application (2024-2034)
4.2.2 Global Cannabinoid Derived Pharmaceutical Historic Market Size Review by Application (2024-2024)
4.2.3 Global Cannabinoid Derived Pharmaceutical Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cannabinoid Derived Pharmaceutical Sales Breakdown by Application (2024-2024)
4.3.2 Europe Cannabinoid Derived Pharmaceutical Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Cannabinoid Derived Pharmaceutical Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Breakdown by Application (2024-2024)
5 North America Cannabinoid Derived Pharmaceutical by Country
5.1 North America Cannabinoid Derived Pharmaceutical Historic Market Size by Country
5.1.1 North America Cannabinoid Derived Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2024)
5.1.3 North America Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2024)
5.2 North America Cannabinoid Derived Pharmaceutical Forecasted Market Size by Country
5.2.1 North America Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2034)
5.2.2 North America Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2034)
6 Europe Cannabinoid Derived Pharmaceutical by Country
6.1 Europe Cannabinoid Derived Pharmaceutical Historic Market Size by Country
6.1.1 Europe Cannabinoid Derived Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2024)
6.1.3 Europe Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2024)
6.2 Europe Cannabinoid Derived Pharmaceutical Forecasted Market Size by Country
6.2.1 Europe Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2034)
6.2.2 Europe Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2034)
7 Asia-Pacific Cannabinoid Derived Pharmaceutical by Region
7.1 Asia-Pacific Cannabinoid Derived Pharmaceutical Historic Market Size by Region
7.1.1 Asia-Pacific Cannabinoid Derived Pharmaceutical Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Cannabinoid Derived Pharmaceutical Forecasted Market Size by Region
7.2.1 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cannabinoid Derived Pharmaceutical Sales in Value by Region (2024-2034)
8 Latin America Cannabinoid Derived Pharmaceutical by Country
8.1 Latin America Cannabinoid Derived Pharmaceutical Historic Market Size by Country
8.1.1 Latin America Cannabinoid Derived Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2024)
8.1.3 Latin America Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2024)
8.2 Latin America Cannabinoid Derived Pharmaceutical Forecasted Market Size by Country
8.2.1 Latin America Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2034)
9 Middle East and Africa Cannabinoid Derived Pharmaceutical by Country
9.1 Middle East and Africa Cannabinoid Derived Pharmaceutical Historic Market Size by Country
9.1.1 Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Cannabinoid Derived Pharmaceutical Forecasted Market Size by Country
9.2.1 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Cara Therapeutics Inc
10.1.1 Cara Therapeutics Inc Company Information
10.1.2 Cara Therapeutics Inc Introduction and Business Overview
10.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Products Offered
10.1.5 Cara Therapeutics Inc Recent Development
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Company Information
10.2.2 Arena Pharmaceuticals Introduction and Business Overview
10.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.2.5 Arena Pharmaceuticals Recent Development
10.3 Cannabics Pharmaceuticals Inc
10.3.1 Cannabics Pharmaceuticals Inc Company Information
10.3.2 Cannabics Pharmaceuticals Inc Introduction and Business Overview
10.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Products Offered
10.3.5 Cannabics Pharmaceuticals Inc Recent Development
10.4 Echo Pharmaceuticals
10.4.1 Echo Pharmaceuticals Company Information
10.4.2 Echo Pharmaceuticals Introduction and Business Overview
10.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.4.5 Echo Pharmaceuticals Recent Development
10.5 Gw Pharmaceuticals
10.5.1 Gw Pharmaceuticals Company Information
10.5.2 Gw Pharmaceuticals Introduction and Business Overview
10.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.5.5 Gw Pharmaceuticals Recent Development
10.6 Inmed Pharmaceuticals
10.6.1 Inmed Pharmaceuticals Company Information
10.6.2 Inmed Pharmaceuticals Introduction and Business Overview
10.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.6.5 Inmed Pharmaceuticals Recent Development
10.7 Insys Therapeutics Inc
10.7.1 Insys Therapeutics Inc Company Information
10.7.2 Insys Therapeutics Inc Introduction and Business Overview
10.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Products Offered
10.7.5 Insys Therapeutics Inc Recent Development
10.8 Larapharm
10.8.1 Larapharm Company Information
10.8.2 Larapharm Introduction and Business Overview
10.8.3 Larapharm Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Larapharm Cannabinoid Derived Pharmaceutical Products Offered
10.8.5 Larapharm Recent Development
10.9 Mgc Pharmaceuticals Ltd
10.9.1 Mgc Pharmaceuticals Ltd Company Information
10.9.2 Mgc Pharmaceuticals Ltd Introduction and Business Overview
10.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Products Offered
10.9.5 Mgc Pharmaceuticals Ltd Recent Development
10.10 One World Cannabis
10.10.1 One World Cannabis Company Information
10.10.2 One World Cannabis Introduction and Business Overview
10.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.10.4 One World Cannabis Cannabinoid Derived Pharmaceutical Products Offered
10.10.5 One World Cannabis Recent Development
10.11 Orpheus Medica
10.11.1 Orpheus Medica Company Information
10.11.2 Orpheus Medica Introduction and Business Overview
10.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Orpheus Medica Cannabinoid Derived Pharmaceutical Products Offered
10.11.5 Orpheus Medica Recent Development
10.12 Receptor Life Sciences
10.12.1 Receptor Life Sciences Company Information
10.12.2 Receptor Life Sciences Introduction and Business Overview
10.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Products Offered
10.12.5 Receptor Life Sciences Recent Development
10.13 Respirerx Pharmaceuticals
10.13.1 Respirerx Pharmaceuticals Company Information
10.13.2 Respirerx Pharmaceuticals Introduction and Business Overview
10.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.13.5 Respirerx Pharmaceuticals Recent Development
10.14 Tetra Bio-Pharma
10.14.1 Tetra Bio-Pharma Company Information
10.14.2 Tetra Bio-Pharma Introduction and Business Overview
10.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Products Offered
10.14.5 Tetra Bio-Pharma Recent Development
10.15 Cardiol Therapeutics
10.15.1 Cardiol Therapeutics Company Information
10.15.2 Cardiol Therapeutics Introduction and Business Overview
10.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Products Offered
10.15.5 Cardiol Therapeutics Recent Development
10.16 United Cannabis Corporation
10.16.1 United Cannabis Corporation Company Information
10.16.2 United Cannabis Corporation Introduction and Business Overview
10.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.16.4 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Products Offered
10.16.5 United Cannabis Corporation Recent Development
10.17 Zynerba Pharmaceuticals
10.17.1 Zynerba Pharmaceuticals Company Information
10.17.2 Zynerba Pharmaceuticals Introduction and Business Overview
10.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Products Offered
10.17.5 Zynerba Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cannabinoid Derived Pharmaceutical Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cannabinoid Derived Pharmaceutical Industrial Chain Analysis
11.4 Cannabinoid Derived Pharmaceutical Market Dynamics
11.4.1 Cannabinoid Derived Pharmaceutical Industry Trends
11.4.2 Cannabinoid Derived Pharmaceutical Market Drivers
11.4.3 Cannabinoid Derived Pharmaceutical Market Challenges
11.4.4 Cannabinoid Derived Pharmaceutical Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cannabinoid Derived Pharmaceutical Distributors
12.3 Cannabinoid Derived Pharmaceutical Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cannabinoid Receptor Type 1 (CB1)
Table 2. Major Company of Cannabinoid Receptor Type 2 (CB2)
Table 3. Major Company of Others
Table 4. Global Cannabinoid Derived Pharmaceutical Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (K Units)
Table 6. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US& Million)
Table 8. Global Cannabinoid Derived Pharmaceutical Market Share in Value by Type (2024-2024)
Table 9. Global Cannabinoid Derived Pharmaceutical Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Cannabinoid Derived Pharmaceutical Sales by Type (2024-2034) & (K Units)
Table 11. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Cannabinoid Derived Pharmaceutical Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type (2024-2034)
Table 14. Global Cannabinoid Derived Pharmaceutical Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (K Units)
Table 16. North America Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2024-2024)
Table 18. Europe Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2024-2024)
Table 22. Latin America Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Cannabinoid Derived Pharmaceutical Sales by Company (2024-2024) & (K Units)
Table 26. Global Cannabinoid Derived Pharmaceutical Sales Share by Company (2024-2024)
Table 27. Global Cannabinoid Derived Pharmaceutical Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Cannabinoid Derived Pharmaceutical Revenue Share by Company (2024-2024)
Table 29. Global Market Cannabinoid Derived Pharmaceutical Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Cannabinoid Derived Pharmaceutical Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2022)
Table 33. Date of Key Manufacturers Enter into Cannabinoid Derived Pharmaceutical Market
Table 34. Key Manufacturers Cannabinoid Derived Pharmaceutical Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cannabinoid Derived Pharmaceutical Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Cannabinoid Derived Pharmaceutical Sales by Region (2024-2024) & (K Units)
Table 38. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Cannabinoid Derived Pharmaceutical Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Region (2024-2024)
Table 41. Global Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Cannabinoid Derived Pharmaceutical Sales by Region (2024-2034) & (K Units)
Table 43. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Cannabinoid Derived Pharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 46. Global Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Cannabinoid Derived Pharmaceutical Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (K Units)
Table 49. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application (2024-2024)
Table 52. Global Cannabinoid Derived Pharmaceutical Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Cannabinoid Derived Pharmaceutical Sales by Application (2024-2034) & (K Units)
Table 54. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Cannabinoid Derived Pharmaceutical Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application (2024-2034)
Table 57. Global Cannabinoid Derived Pharmaceutical Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) (K Units)
Table 59. North America Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) (K Units)
Table 61. Europe Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) (K Units)
Table 65. Latin America Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (K Units)
Table 69. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2024)
Table 72. North America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (K Units)
Table 73. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (K Units)
Table 77. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (K Units)
Table 81. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 108. Cara Therapeutics Inc Company Information
Table 109. Cara Therapeutics Inc Introduction and Business Overview
Table 110. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product
Table 112. Cara Therapeutics Inc Recent Development
Table 113. Arena Pharmaceuticals Company Information
Table 114. Arena Pharmaceuticals Introduction and Business Overview
Table 115. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 117. Arena Pharmaceuticals Recent Development
Table 118. Cannabics Pharmaceuticals Inc Company Information
Table 119. Cannabics Pharmaceuticals Inc Introduction and Business Overview
Table 120. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product
Table 122. Cannabics Pharmaceuticals Inc Recent Development
Table 123. Echo Pharmaceuticals Company Information
Table 124. Echo Pharmaceuticals Introduction and Business Overview
Table 125. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 127. Echo Pharmaceuticals Recent Development
Table 128. Gw Pharmaceuticals Company Information
Table 129. Gw Pharmaceuticals Introduction and Business Overview
Table 130. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 132. Gw Pharmaceuticals Recent Development
Table 133. Inmed Pharmaceuticals Company Information
Table 134. Inmed Pharmaceuticals Introduction and Business Overview
Table 135. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 137. Inmed Pharmaceuticals Recent Development
Table 138. Insys Therapeutics Inc Company Information
Table 139. Insys Therapeutics Inc Introduction and Business Overview
Table 140. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product
Table 142. Insys Therapeutics Inc Recent Development
Table 143. Larapharm Company Information
Table 144. Larapharm Introduction and Business Overview
Table 145. Larapharm Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Larapharm Cannabinoid Derived Pharmaceutical Product
Table 147. Larapharm Recent Development
Table 148. Mgc Pharmaceuticals Ltd Company Information
Table 149. Mgc Pharmaceuticals Ltd Introduction and Business Overview
Table 150. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product
Table 152. Mgc Pharmaceuticals Ltd Recent Development
Table 153. One World Cannabis Company Information
Table 154. One World Cannabis Introduction and Business Overview
Table 155. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. One World Cannabis Cannabinoid Derived Pharmaceutical Product
Table 157. One World Cannabis Recent Development
Table 158. Orpheus Medica Company Information
Table 159. Orpheus Medica Introduction and Business Overview
Table 160. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Orpheus Medica Cannabinoid Derived Pharmaceutical Product
Table 162. Orpheus Medica Recent Development
Table 163. Receptor Life Sciences Company Information
Table 164. Receptor Life Sciences Introduction and Business Overview
Table 165. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product
Table 167. Receptor Life Sciences Recent Development
Table 168. Respirerx Pharmaceuticals Company Information
Table 169. Respirerx Pharmaceuticals Introduction and Business Overview
Table 170. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 171. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 172. Respirerx Pharmaceuticals Recent Development
Table 173. Tetra Bio-Pharma Company Information
Table 174. Tetra Bio-Pharma Introduction and Business Overview
Table 175. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 176. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product
Table 177. Tetra Bio-Pharma Recent Development
Table 178. Cardiol Therapeutics Company Information
Table 179. Cardiol Therapeutics Introduction and Business Overview
Table 180. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 181. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product
Table 182. Cardiol Therapeutics Recent Development
Table 183. United Cannabis Corporation Company Information
Table 184. United Cannabis Corporation Introduction and Business Overview
Table 185. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 186. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product
Table 187. United Cannabis Corporation Recent Development
Table 188. Zynerba Pharmaceuticals Company Information
Table 189. Zynerba Pharmaceuticals Introduction and Business Overview
Table 190. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 191. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 192. Zynerba Pharmaceuticals Recent Development
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Cannabinoid Derived Pharmaceutical Market Trends
Table 196. Cannabinoid Derived Pharmaceutical Market Drivers
Table 197. Cannabinoid Derived Pharmaceutical Market Challenges
Table 198. Cannabinoid Derived Pharmaceutical Market Restraints
Table 199. Cannabinoid Derived Pharmaceutical Distributors List
Table 200. Cannabinoid Derived Pharmaceutical Downstream Customers
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Cannabinoid Derived Pharmaceutical Product Picture
Figure 2. Global Cannabinoid Derived Pharmaceutical Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cannabinoid Derived Pharmaceutical Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Cannabinoid Derived Pharmaceutical Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Cannabinoid Receptor Type 1 (CB1)
Figure 6. Global Cannabinoid Receptor Type 1 (CB1) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Cannabinoid Receptor Type 2 (CB2)
Figure 8. Global Cannabinoid Receptor Type 2 (CB2) Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Cannabinoid Derived Pharmaceutical Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type in 2022 & 2034
Figure 13. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 14. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 15. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabinoid Derived Pharmaceutical Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabinoid Derived Pharmaceutical Revenue in 2022
Figure 25. Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Epilepsy
Figure 27. Global Epilepsy Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Migraine
Figure 29. Global Migraine Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Multiple Sclerosis
Figure 31. Global Multiple Sclerosis Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Cannabinoid Derived Pharmaceutical Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application in 2022 & 2034
Figure 36. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 37. North America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 38. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 39. Europe Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 42. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Cannabinoid Derived Pharmaceutical Manufacturing Cost Structure
Figure 47. Cannabinoid Derived Pharmaceutical Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed